Natera is a diagnostics company that develops and sells molecular testing services globally. Its offerings span oncology (including blood tests for monitoring cancer recurrence and tissue-based genomic profiling), reproductive health (prenatal screening and carrier screening tests), transplant monitoring, and kidney disease assessment. The company distributes its tests through direct sales to laboratories and medical providers, as well as through a cloud-based software platform called Constellation, and maintains partnerships with genomics firms and pharmaceutical companies to expand its testing capabilities.
1Y: 410.56 (+150.9%) · range 160.21–410.56
entry readiness 0 · NOT READY · exit proximity 70
Value area 184.00–285.97 · 0% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.220 | Sep 25, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +15.16% | +15.16% | 12/20d |
| 40d | +15.16% | +15.16% | 12/40d |